EUVIMEDEUVIMED entdecken
Editorial

Real world tirzepatide treatment for fatty liver disease

Soe Thiha Maung, Vincent Wai-Sun Wong

Hepatology International · 2026-04 · 20 (2) · 259-260

DOI: 10.1007/s12072-026-11065-9 ↗

Kurz gefasst

Editorial in der Zeitschrift Hepatology International, online erschienen am 03.03.2026. Verfasst von Soe Thiha Maung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Die Arbeit nennt 8 Literaturangaben. Gefördert von: University Grants Committee, Chinese University of Hong Kong.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Ma Har Myaing Hospital, Yangon, Myanmar.
  • Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. wongv@cuhk.edu.hk.
  • State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. wongv@cuhk.edu.hk.

Förderung

  • University Grants Committee
  • Chinese University of Hong Kong

Zitieren

APA

Maung, S. T., & Wong, V. W. (2026). Real world tirzepatide treatment for fatty liver disease. Hepatology International, 20(2), 259-260. https://doi.org/10.1007/s12072-026-11065-9

Vancouver

Maung ST, Wong VW. Real world tirzepatide treatment for fatty liver disease. Hepatology International. 2026;20(2):259-260. doi:10.1007/s12072-026-11065-9

BibTeX
@article{Maung2026,
  author = {Maung, Soe Thiha and Wong, Vincent Wai-Sun},
  title = {Real world tirzepatide treatment for fatty liver disease},
  journal = {Hepatology International},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {259--260},
  doi = {10.1007/s12072-026-11065-9}
}
Kostenlos starten →